HomeXFOR • NASDAQ
add
X4 Pharmaceuticals Inc
Previous close
$3.89
Day range
$3.84 - $4.00
Year range
$1.35 - $26.83
Market cap
339.25M USD
Avg Volume
683.12K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 1.76M | 215.18% |
Operating expense | 24.02M | -31.03% |
Net income | -29.82M | 18.75% |
Net profit margin | -1.69K | 74.22% |
Earnings per share | -0.69 | 87.22% |
EBITDA | -22.39M | 34.61% |
Effective tax rate | 0.10% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 122.19M | -9.47% |
Total assets | 163.56M | -8.20% |
Total liabilities | 101.94M | -14.01% |
Total equity | 61.62M | — |
Shares outstanding | 87.44M | — |
Price to book | 1.59 | — |
Return on assets | -42.07% | — |
Return on capital | -51.16% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -29.82M | 18.75% |
Cash from operations | -27.82M | 18.25% |
Cash from investing | -28.67M | -79.98% |
Cash from financing | 86.90M | — |
Net change in cash | 30.41M | 161.08% |
Free cash flow | -14.18M | 35.28% |
About
Founded
Mar 13, 2019
Headquarters
Website
Employees
143
